(Rac)-Beraprost sodium
Based on 1 Customer Validation
(Rac)-Beraprost ((Rac)-ML 1129) sodium is a racemic isomer of Beraprost sodium (HY-13569A). Beraprost sodium is an orally active prostacyclin analog that inhibits the release of Ca2+ from intracellular storage sites by binding to prostacyclin membrane receptors (Prostaglandin Receptor), leading to relaxation of smooth muscle cells and vasodilation. Beraprost sodium has vasodilatory, antiplatelet, and cytoprotective effects, making it promising for research in the field of cardiovascular diseases, such as thromboangiitis obliterans and atherosclerosis.
For research use only. We do not sell to patients.
- Purity: 99.0%
- CAS No.: 88475-69-8
- Formula: C24H29NaO5
- Molecular Weight:420.47
-
Storage:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
-
HY-N2736
3′,4′,7-Trihydroxyflavone
-
HY-100441
Treprostinil
-
HY-W738639
18-Hydroxy-11-deoxy corticosterone
-
HY-B0813
Treprostinil diethanolamine
-
HY-113254
13,14-Dihydro-15-keto-PGE2
-
HY-B1108S
Labetalol hydrochloride-d5
-
HY-114623
Prostaglandin D2 methyl ester
-
HY-113444
Prostaglandin D3
-
HY-113264
PGD2 ethanolamide
-
HY-18541
KT172
-
HY-100441R
Treprostinil (Standard)
-
HY-B0683S
Limaprost-d3
Biological Activity
Chemical Information
-
CAS No. 88475-69-8
-
Appearance Solid
-
Molecular Weight 420.47
-
Formula C24H29NaO5
-
Color White to off-white
-
SMILES
O=C(CCCC1=CC=CC2=C1OC3CC(C(C23)/C=C/C(C(CC#CC)C)O)O)O[Na]
-
Synonyms
(Rac)-TRK-100; (Rac)-ML 1129 sodium
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Purity & Documentation
-
Data Sheet (269 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Li S, et al. Beraprost sodium mitigates renal interstitial fibrosis through repairing renal microvessels. J Mol Med (Berl). 2019 Jun;97(6):777-791. [Content Brief]
[2]. Yan P, et al. Clinical efficacy and safety of beraprost sodium in the treatment of nephrotic syndrome: A meta-analysis. Medicine (Baltimore). 2023 Oct 20;102(42):e34958. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
(Rac)-Beraprost sodium Related Classifications
HY-Z7721 Related Classifications
Powered by Bioz